Protocol to request
SapC-DOPS-fGCase treatment of MLOs
Research Article
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies
DOI: 10.7554/eLife.109518